Federated Hermes’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-801
| Closed | -$1.25K | – | 2206 |
|
|
2023
Q1 | $1.25K | Sell |
801
-249,657
| -100% | -$390K | ﹤0.01% | 2032 |
|
|
2022
Q4 | $160K | Sell |
250,458
-264,583
| -51% | -$169K | ﹤0.01% | 1592 |
|
|
2022
Q3 | $685K | Sell |
515,041
-13,523
| -3% | -$18K | ﹤0.01% | 1242 |
|
|
2022
Q2 | $1.17M | Buy |
528,564
+115,009
| +28% | +$255K | ﹤0.01% | 1084 |
|
|
2022
Q1 | $2.56M | Buy |
413,555
+307,351
| +289% | +$1.9M | 0.01% | 965 |
|
|
2021
Q4 | $1.34M | Buy |
106,204
+44,089
| +71% | +$556K | ﹤0.01% | 1168 |
|
|
2021
Q3 | $5.69M | Buy |
62,115
+30,519
| +97% | +$2.8M | 0.01% | 795 |
|
|
2021
Q2 | $1.68M | Buy |
+31,596
| New | +$1.68M | ﹤0.01% | 1148 |
|
|
2019
Q4 | – | Sell |
-95
| Closed | -$2K | – | 2288 |
|
|
2019
Q3 | $2K | Buy |
+95
| New | +$2K | ﹤0.01% | 2039 |
|